Detalles de la búsqueda
1.
Serum levels of VCAM-1 are associated with survival in patients treated with nivolumab for NSCLC.
Eur J Clin Invest
; 52(1): e13668, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34390488
2.
Novel Emerging Molecular Targets in Non-Small Cell Lung Cancer.
Int J Mol Sci
; 22(5)2021 Mar 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33807876
3.
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients.
Mol Med
; 25(1): 15, 2019 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31029076
4.
Serum PCSK9 levels at the second nivolumab cycle predict overall survival in elderly patients with NSCLC: a pilot study.
Cancer Immunol Immunother
; 68(8): 1351-1358, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31327024
5.
Serial Troponin for Early Detection of Nivolumab Cardiotoxicity in Advanced Non-Small Cell Lung Cancer Patients.
Oncologist
; 23(8): 936-942, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29567824
6.
Circulating Cell-Free DNA and Circulating Tumor Cells as Prognostic and Predictive Biomarkers in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Chemotherapy.
Int J Mol Sci
; 18(5)2017 May 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28492516
7.
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples.
BMC Cancer
; 16: 692, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27578032
8.
Next-Generation Sequencing Workflow for NSCLC Critical Samples Using a Targeted Sequencing Approach by Ion Torrent PGM™ Platform.
Int J Mol Sci
; 16(12): 28765-82, 2015 Dec 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26633390
9.
Role of immunotherapy in the treatment of advanced non-small-cell lung cancer.
Future Oncol
; 10(1): 79-90, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24328411
10.
CD34+DNAM-1brightCXCR4+ haemopoietic precursors circulate after chemotherapy, seed lung tissue and generate functional innate-like T cells and NK cells.
Front Immunol
; 15: 1332781, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390333
11.
Glyceraldehyde-3-phosphate dehydrogenase gene over expression correlates with poor prognosis in non small cell lung cancer patients.
Mol Cancer
; 12(1): 97, 2013 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-23988223
12.
Prognostic Role of Soluble and Extracellular Vesicle-Associated PD-L1, B7-H3 and B7-H4 in Non-Small Cell Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.
Cells
; 12(6)2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36980174
13.
Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer.
Cancer Immunol Immunother
; 61(9): 1463-72, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22318401
14.
A Circulating Risk Score, Based on Combined Expression of Exo-miR-130a-3p and Fibrinopeptide A, as Predictive Biomarker of Relapse in Resectable Non-Small Cell Lung Cancer Patients.
Cancers (Basel)
; 14(14)2022 Jul 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884472
15.
The Role of the Immune Metabolic Prognostic Index in Patients with Non-Small Cell Lung Cancer (NSCLC) in Radiological Progression during Treatment with Nivolumab.
Cancers (Basel)
; 13(13)2021 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34206545
16.
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer.
Clin Breast Cancer
; 21(3): 218-230.e6, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33008754
17.
Radiomic Detection of EGFR Mutations in NSCLC.
Cancer Res
; 81(3): 724-731, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33148663
18.
Clinical Outcomes and Toxic Effects of Single-Agent Immune Checkpoint Inhibitors Among Patients Aged 80 Years or Older With Cancer: A Multicenter International Cohort Study.
JAMA Oncol
; 7(12): 1856-1861, 2021 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34734989
19.
Treatment Patterns and Clinical Outcomes Among Patients With ROS1-rearranged Non-small-cell Lung Cancer Progressing on Crizotinib.
Clin Lung Cancer
; 21(5): e478-e487, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32409267
20.
ADP ribose polymerase inhibitors for treating non-small cell lung cancer: new additions to the pharmacotherapeutic armamentarium.
Expert Opin Pharmacother
; 21(6): 679-686, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32073315